What is the impact of underweight on self-reported health trajectories and mortality rates: a cohort study by Lorem, Geir F et al.
RESEARCH Open Access
What is the impact of underweight on self-
reported health trajectories and mortality
rates: a cohort study
Geir Fagerjord Lorem1*, Henrik Schirmer2,3,4 and Nina Emaus1
Abstract
Background: Utilizing a cohort study design combining a survey approach with repeated physical examinations,
we examined the independent effects of BMI on mortality and self-reported health (SRH) and whether these
independent effects change as people grow older.
Methods: The Tromsø Study consists of six surveys conducted in the municipality of Tromsø, Norway, with large
representative samples of a general population. In total, 31,985 subjects participated in at least one of the four
surveys administered between 1986 and 2008. Outcomes of interest were SRH and all-cause mortality.
Results: Overweight and underweight subjects reported significantly lower levels of SRH, but age affected the thinnest
subjects more than all others. The SRH trajectory of underweight subjects at age 25 was slightly above the other categories
(0.08), but it fell to −.30 below the reference category at age 90. For obese subjects, the difference was −0.15 below the
reference category at age 25 and −0.18 below at age 90. This implies that even though a low BMI was slightly beneficial at
a young age, it represented an increasing risk with age that crossed the reference curve at age 38 and even crossed the
obese trajectory at age 67 in the full fitted model. The proportional hazard ratio for those who were underweight was 1.69
(95% CI: 1.38-2.06) for all-cause death as compared to 1.12 (95% CI: 1.02-1.23) for obese subjects.
Conclusion: BMI affected SRH and all-cause mortality independently from comorbidity, mental health, health-related
behaviors and other biological risk factors. Being underweight was associated with excess mortality as compared to all
others, and age affected the thinnest subjects more than all others. Weight increase was beneficial for mortality but not for
SRH among the underweight. The rapid decline of SRH with increasing age suggests that particular attention should be
paid to underweight after 38 years of age.
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General advice for clinicians
1. Low body mass is not beneficial in the long term; it
affects self-reported health and is associated with ex-
cess mortality. It is crucial to avoid underweight, not
only overweight. The golden mean is lower than the
population mean but should not be too low.
2. Increasing weight to the normal range (18.5-25 kg/m2)
from underweight (<18.5 kg/m2) is beneficial for
comorbidity and mortality but not necessarily self-
reported health.
3. There are more daily smokers among those with low
BMI, and just as many physically inactive as among those
who are overweight. General advice on health-related
behavior is therefore also valid for those who are thin.
4. It is the sum of risks that is crucial, and underweight
persons should be screened for risk to the same
extent as obese persons
Background
Being thin is an ideal embedded in Western culture [1],
but is it healthy? Being thin or underweight (i.e. BMI
<18.5 kg/m2) is not necessarily a negative characteristic
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[2–4]. It constitutes a rather complex group, since
people can have a low BMI for a number of reasons: It
can be the result of healthy living (e.g. healthy diet and
exercise), but it may also apply to individuals with eating
disorders or be due to malnutrition or weight loss due
to clinical or sub-clinical disease [5–7].
Underweight can potentially by itself lead to adverse
health effects such as higher disease burden, it affects
the outcome for several medical conditions, and it is a
known risk factor for older people (>65 years) [8–15].
Weight loss is another factor known to have a potential
negative effect on health [16–20]. Even a modest decline
in body weight is a known risk of mortality in older
adults [21]. It has been shown how body weight declines
three to 5 years before cardiovascular deaths [22]. It is
known that Individuals with eating disorders have
significantly elevated mortality rates [23], and these
conditions have a severe impact on the patient’s health-
related quality of life [24]. However, it remains
unanswered how these outcomes are affected by low
BMI in a general population and whether this risk
changes when people grow older.
Our intention was to examine how body mass affected
two different aspects of health: Mortality, which con-
cerns survival, and self-rated health (SRH), which is a
person’s general assessment of his/her own health and
health-related quality of life. SRH is associated with a
broad range of objective health outcomes, including
mortality [25], subclinical and clinical disease [26], and
health service use [27]. Since being thin can also be
beneficial for health, it is of interest to investigate
whether the SRH benefits at some point in life outweigh
the disadvantages of very low body mass. We thus
wanted to examine the relationship between under-
weight (i.e. BMI <18.5 kg/m2), SRH and mortality.
Methods
Our aim was to estimate the independent effects of BMI
on mortality and SRH from youth and estimate whether
any independent effects change as people grow older.
The design and comprehensive database of the Tromsø
Study allowed us to examine the relationship between
body weight and SRH throughout life in the general
population, including the impact of a broad range of
other health-related factors. The Tromsø Study (TS)
consisted of six repeated population health examinations
carried out in 1974 (TS1), 1979-80 (TS2), 1986-87
(TS3), 1994-95 (TS4), 2001 (TS5), and 2007-08 (TS6).
The six surveys had the same general design. Based on
the official population registry, residents of the munici-
pality of Tromsø were invited to take part in the survey.
The aim was to include large, representative samples of
the Tromsø population, with the invitation of entire
birth cohorts and random samples. The attendance rate
was high (66-75%). In all surveys, a questionnaire was
enclosed in the invitation. Over the years, the question-
naires were expanded to include questions about a wide
range of diseases and symptoms, dietary habits, other
lifestyle aspects, use of medication, sleeping patterns,
socio-economic status, and use of health care services.
The physical examination consisted of blood samples
and measurements of blood pressure, height and weight
[28]. SRH was introduced in 1986.
Data
We used TS 3-6 for the latent trajectory model. In total,
31,985 subjects participated in at least one of the four
surveys administered between 1986 and 2008. Three
thousand six hundred forty-nine subjects participated
each time, 5905 thrice, 8664 twice, while 13,766 subjects
participated once. The latent trajectory model required
at least two measuring points and thus included 9506
men and 8712 women [29].
We used TS4 with updated measures for the Cox
proportional hazard model. TS4 was executed in 1994-
95 and included 12,014 men and 13,237 women aged 25
to 97 at baseline. We excluded subjects who had missing
values for SRH (n = 40) or missing medical conditions,
physical condition or mental health symptoms (n = 886).
Subjects who attended in 2001 (n = 6814) and 2007/8
(n = 9316) had their SRH and risk factor values updated
at the time of their examination. Follow-up time
extended from the date of study entry in 1994 to the date of
death or the end of study follow-up on December 31, 2015.
Variables
The participants completed well-validated questionnaires
that included questions on a broad range of diseases,
symptoms, health behavior, social conditions, education,
and level of physical activity [28]. Outcomes of interest
were SRH and all-cause mortality. SRH was reported by
answering the survey question ‘What is your current
state of health?’ in a range from Poor (1) to Very Good
(4). Time of death was retrieved from the Norwegian
National Causes of Death Registry. The degree of
coverage of the registry is near-complete [30].
BMI and age were the independent variables of inter-
est. The conceptual model was that BMI has an effect
on SRH that is moderated by age (Fig. 1). The other
variables were treated as confounders for the sake of the
presentation. Age was registered at attendance. Specially
trained personnel took non-fasting blood samples and
measured blood pressure (SBP/DBP), resting heart rate
(RHR), body weight and height. Comorbid diseases were
self-reported specific medical conditions. We selected 13
symptomatic medical conditions reported in all panels.
These were psoriasis, food allergies, chronic bronchitis, mi-
graine, ulcer, asthma, thyroid disease, arthritis, myocardial
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infarction, cerebrovascular stroke, diabetes, osteoporosis,
and angina, which all have a varied impact on SRH. We
therefore utilized the Health Impact Index (HII) to measure
the comorbid conditions. HII classifies patients with co-
morbid disease according to the impact that each condition
has on SRH by assigning a weight to each condition. HII
equals the total score of each condition of the participant.
HII thus considers both the severity and joint effects of the
conditions [31].
Mental distress was based on well validated self-report
symptom inventories comprising questions representative
of the symptom configurations of anxiety and depression
commonly observed among outpatients. Each answer is
scored from 1 to 4. The measurement is the average score.
The mental health index (CONOR-MHI) was used at
TS4. In the following surveys (TS5-6), the Hopkins
Symptom Checklist (HSCL) was used [32]. The CONOR-
MHI has been compared with the HSCL with reasonably
good agreement. It was highly correlated with HSCL-10
(r = 0.8). A cut-off level of 2.15 for significant symptoms is
equivalent to the 1.85 level in HSCL-10 [33]. We stan-
dardized the variable for better longitudinal comparison
in the regression model. TS3 did not include any validated
mental health measures and these were coded as missing.
Physical exercise in leisure time was measured by
answers to ‘How often do you exercise?’, categorized as
inactive (0), light (1), moderate (2-3), and intensive (3-7)
physical activity. This scale has been widely used in
Scandinavian studies, and physical activity levels have
been correlated with physical fitness [34].
Fig. 1 Directed acyclic graph showing the causal relationships that guide the conceptual model and its transition into the statistical model
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Analysis
We performed the analysis in three stages using Stata
v14. The first stage examined the overall distribution of
SRH for age and BMI groups for each panel; the second
stage utilized the repeated measures to estimate how
SRH changed for different BMI groups as the subjects
grow older. The ability of SRH to predict all-cause death
is well-known [25]. The third stage thus examined
whether BMI and SRH also affected mortality.
Stage 1: We used cross tabulation and ANOVA to
examine the distribution of the subjects and mean SRH
for age versus BMI.We divided the subjects into 10-year
age groups and BMI into <18.5 Kg/m2 (Underweight),
18.5-22.99 kg/m2 (Lower normal) 23-25.99 kg/m2 (Upper
normal), 25-30 kg/m2, >30 kg/m2 (Obese). BMI
>25 kg/m2 is also referred to as overweight [2–4].
We know that SRH declines with increasing age
[31], and we used ANOVA to determine the effect
of BMI on SRH for the age groups within each
panel. The post hoc analysis included a pairwise
comparison of the BMI groups.
Stage 2: We used latent trajectory modeling to examine
how SRH changes over time. The method is also known
as growth curves because it was first used to estimate the
normal growth rate of infants. It consists of multilevel
regression modeling that utilizes the fact that the data are
multiple observations over time nested within subjects.
Latent trajectory models are a special case of random
coefficient models where we allow the coefficient of time
to vary randomly between subjects. This method allowed
us to explicitly model the shape of trajectories of individual
subjects over time and how these trajectories varied based
on occasion- and subject-level covariates [29].
Our purpose was to investigate the relationship
between SRH and age and how this relationship varied
between different BMI groups. The units for a longitu-
dinal setting are time of attendance (j) and the clusters
are subjects (i). There are different ways of modeling
nonlinear development, using polynomial functions. In
our study, time is represented as age, cohort, and period.
Ageij is the age at the date of the survey for each subject.
Cohort is the birth year. Periodi is the attendance year
for each occasion. Time is described by the equation
Ageij = Periodi - Cohortj. One time variable will thus be
collinear with the two others and can be left out of the
model. We can now consider a model that includes the
two time scales (Ageij and Periodi) as covariates as well
as gender, pathology (comorbid diseases and mental
distress), physical examination measurements (resting
heart rate, BMI, cholesterol and systolic blood pressure),
physical exercise and smoking habits. We started by
modeling the time as linear, then quadratic, cubic and
quartic. We also modeled interaction between all covari-
ates with age. Interaction coefficients with p > .05 were
removed from the model one at a time until we reached
the final model:
SRHij ¼ β1bmiij þ β2bmi  ageij þ β3ageij þ β4age2ij
þβ5age3ij þ β6age4ij þ β7periodj
þβ8sexj þ β9HIIij þ β10MHI=HSCLij
þβ11resting HRij þ β12bloodpressureij
þ β13cholesterolij þ β14Phys:actij
þβ15smokeij þ β0 þ ζ1j þ εij
The random intercept (ζ1j) and the occasion specific
error (εij) allow the responses (SRHij) to deviate from the
polynomial function. Adding age to the slope in the ran-
dom part (ζ2 ageij) did not significantly improve the
model. The figure is the response (SRHij) as a function
of age and BMI.
Loss to follow-up always causes loss of information
that cannot be recovered. The concern is that loss to
follow-up can be systematic due to known or underlying
physical conditions. The simplest approach to dealing
with missing data is to restrict the analysis to complete
cases (CC), i.e. individuals with no missing values. This
can induce bias; however, inverse probability weighting
(IPW) is a commonly used method to correct such bias
[35]. The probabilities are obtained by modeling the ob-
served loss to follow-up as a function of subject charac-
teristics that determined the group recorded at baseline.
These were BMI, comorbidity, blood pressure, choles-
terol, and resting heart rate. We found that thin subjects
and those with higher levels of comorbidity, resting
heart rate and blood pressure were more likely to be
missing, while higher cholesterol levels were beneficial.
Weights from the model ranged from 1.07 to 1.81, with
a mean of 1.29. We then performed a CC analysis, but
weighted the complete cases by the inverse of their
probability of not being missing. That meant that those
with a small chance of being observed were given in-
creased weight, to compensate for similar subjects who
were missing.
Stage 3: We used Cox proportional hazard regression
to estimate hazard ratios (HRs) of all-cause death using
baseline scores for BMI and gender in addition to age,
comorbid disease, mental distress, and physical examin-
ation scores as time-dependent covariates updated in
2001 and 2007-08. Time at risk was the person-time
measured in days from the first attendance date. The
proportional hazard assumption was verified for BMI
by visual inspection of log minus log survival curves
and by tests of Schoenfeld residuals; we therefore
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included the intereaction between time and SRH in
the model.
Results
Characteristics of the sample
Table 1 shows the distribution of observations for each
BMI group. Underweight subjects reported lower levels
of SRH in all panels and also more comorbid conditions.
Most underweight subjects are among the youngest
(<30 years) and oldest subjects (>70 years) in all panels.
The age-standardized proportion of underweight sub-
jects declined from 2.8% in TS3 to 1.5% in TS4, 1.3% in
TS5, and 0.8% in TS6. Most of the underweight subjects
were females (~77-85%). Among the underweight, the
proportion who smoke is greater and the proportion
who exercise at least once a week is smaller. The cardio-
vascular risk factors are both against and in favor of the
group. When comparing the underweight subjects with
the obese, we notice lower resting heart rates, fewer
smokers and slightly higher physical activity levels
among the obese. Blood pressure and cholesterol levels
were better among those who were underweight,
whereas comorbidity and mental distress levels were bet-
ter in the obesity group. The SRH levels were better for
the underweight group in T3; in T4-6, however, the
obese subjects had higher SRH than the underweight
subjects.
When we tracked those who were underweight in
1986 (n = 299), we see that 27.4% (n = 109) died during
the 29 years of follow-up. The mortality rate was 0.021,
which is twice the rate (0.010) of the lower normal
weight category (18.5-23 kg/m2). This occurred in spite
of 76% of them being younger than 40 and a gradual in-
crease in the mean BMI from 18.1 to 20.9 kg/m2 (BMI-
diff = 0.74, Range − 2.80, 3.52). Some subjects changed
weight drastically: 16 became overweight (25-29.99 kg/
m2), and 15 reached the upper normal weight range, but
most subjects (n = 193) remained in or below the lower
normal range (<23 kg/m2). Fifty-eight of those remained
underweight, and 75 were observed only once in the
dataset. Remaining in the initial weight group was bene-
ficial for SRH and comorbidity (HII) for all BMI categor-
ies with one exception, viz. those who had been thin and
ended up within the normal weight range (18.5-
24.99 kg/m2) at the end of the study. This group re-
ported significantly fewer comorbid conditions (0.91 vs.
2.22) and their mortality rate (.0023 deaths per person-
year) was lower than for those who remained under-
weight throughout the study. Despite this, 68.4% re-
ported good or very good SRH in contrast to 77.8% of
those who remained thin (Additional file 1: Table S1).
Those who were the thinnest subjects at the final
panel (n = 80), had on average lost weight (BMI-
diff = −1.77, Range: −7.53, 0.38). Twenty had remained
underweight, 45 had lost weight from 18.5-22.99 kg/m2,
five subjects had been overweight and only one of those
had been obese, while 10 were observed only once in the
dataset. 25.3% (n = 20) died during the remaining 8 years
of follow-up (mortality rate 0.031). Figure 2 shows how
the BMI of those who started or ended as underweight
in our study changed over the time of observation.
The overall effect of BMI
Table 2 shows the observations according to age and
BMI for each panel and the distribution of SRH across
age and BMI. One-way ANOVA showed a significant ef-
fect of BMI on levels of SRH for almost all age groups in
all cross-sectional panels. Pairwise comparison revealed
that those who were overweight and underweight re-
ported significantly lower SRH levels, while the differ-
ences within the upper and lower normal range often
did not show significant differences. SRH was highest
for the upper normal range (23-24.99 kg/m2) in all age
groups except for two exceptions in the oldest age
group, in which overweight subjects (25-29.99 kg/m2)
had marginally but statistically significant higher levels
of SRH in TS3 and TS6. The upper normal range is
therefore used as reference category for the regression
models. The youngest underweight subjects reported
only slightly lower SRH levels than the reference cat-
egory, while the underweight subjects at 70 years were
below all other BMI categories.
The decline in SRH between age groups for those in
the lowest weight category was most striking. SRH
started out higher than for those in the normal range in
all panels, but declined below all other BMI categories,
and even passed obesity at around the 60 years age
group. The pairwise comparisons between SRH levels
for subjects with BMI <18.5 kg/m2 were significantly dif-
ferent from the overweight groups. The underweight
group consequently had significant higher age-related
decline before confounders such as time, comorbidity,
mental health, and other risk factors were controlled for.
Body weight and self-rated health with increasing age
Table 3 shows results of the complete case (CC) and in-
verse probability weighted (IPW) analyses. Figure 3
shows the results from the latent trajectory models and
displays how SRH changed over time. Upper normal
range (22-24.99 kg/m2) was our reference category. We
see that SRH declined for all BMI groups with increasing
age; however, the model also predicts different trajector-
ies for different BMI levels. Having a BMI above 30 kg/
m2 (−0.139, 95% CI: -0.257, −0.021) was never beneficial
for SRH as the subjects grew older. For subjects with
BMI below 18.5 kg/m2, we see a positive gap in SRH
scores compared to the reference category (0.226, 95%
CI: -0.094, 0.546); however, SRH interacted with age,
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Table 1 Characteristics of all participants for BMI groups for each wave
Panel <18.5 18.5-22.99 23-24.99 25-29.99 >30 P-value c
Kg/m2 Kg/m2 Kg/m2 kg/m2 kg/m2
Frequency Tromsø 3 299 7075 4588 5226 945
Tromsø 4 327 6958 5789 9391 2730
Tromsø 5 86 1378 1534 3392 1484
Tromsø 6 80 1996 2175 5355 2454
SRH (% reporting good/very good) Tromsø 3 75.4% 82.0% 82.4% 76.9% 68.3% <0.001
Tromsø 4 54.8% 74.5% 74.1% 68.7% 54.9% <0.001
Tromsø 5 41.3% 64.6% 68.5% 64.4% 54.0% <0.001
Tromsø 6 46.6% 70.2% 71.9% 67.0% 53.9% <0.001
Age (Mean)a Tromsø 3 35.3 37.2 40.0 42.5 43.1 <0.001
Tromsø 4 49.5 44.1 46.7 50.1 53.2 <0.001
Tromsø 5 64.5 56.7 58.5 60.7 61.9 <0.001
Tromsø 6 63.4 56.5 57.4 59.0 59.1 <0.001
Gender (% male) Tromsø 3 17.5% 35.6% 58.6% 67.5% 50.8% <0.001
Tromsø 4 22.3% 33.5% 51.5% 58.3% 42.3% <0.001
Tromsø 5 15.0% 31.1% 43.2% 50.6% 39.8% <0.001
Tromsø 6 23.3% 29.5% 46.4% 54.1% 47.2% <0.001
Comorbidity (mean HII)b Tromsø 3 0.54 0.43 0.44 0.54 0.70 <0.001
Tromsø 4 1.26 0.78 0.82 1.04 1.39 <0.001
Tromsø 5 2.50 1.54 1.38 1.67 2.27 <0.001
Tromsø 6 2.53 1.44 1.40 1.57 2.11 <0.001
Mental distress (mean MHI/HSCL)b Tromsø 3 . . . . .
Tromsø 4 1.66 1.54 1.51 1.50 1.54 <0.001
Tromsø 5 1.32 1.30 1.24 1.22 1.25 <0.001
Tromsø 6 1.43 1.31 1.28 1.27 1.31 <0.001
Resting heart rate (mean BPM)b Tromsø 3 80.7 75.2 73.0 73.8 78.0 <0.001
Tromsø 4 76.9 72.8 71.2 72.1 75.8 <0.001
Tromsø 5 75.4 71.1 69.3 69.6 72.7 <0.001
Tromsø 6 70.3 64.7 63.5 64.7 67.6 <0.001
Systolic blood pressure (mean mmHG) Tromsø 3 120.3 123.4 128.1 133.4 138.1 <0.001
Tromsø 4 129.5 127.5 133.1 139.4 148.2 <0.001
Tromsø 5 137.3 132.4 135.7 140.6 144.6 <0.001
Tromsø 6 132.3 129.0 132.3 138.3 142.1 <0.001
Total cholesterol (mean) Tromsø 3 5.25 5.45 5.89 6.26 6.48 <0.001
Tromsø 4 5.72 5.65 5.99 6.35 6.59 <0.001
Tromsø 5 5.91 5.90 6.07 6.26 6.31 <0.001
Tromsø 6 5.53 5.45 5.59 5.69 5.61 <0.001
Physical activity (% inactive) Tromsø 3 8.4% 10.8% 10.0% 11.0% 9.2% 0.255
Tromsø 4 64.3% 46.6% 45.1% 50.8% 62.7% <0.001
Tromsø 5 48.5% 29.6% 30.8% 32.7% 37.5% <0.001
Tromsø 6 31.7% 15.2% 17.1% 18.9% 30.3% <0.001
Smoking habits (% daily smokers) Tromsø 3 64.3% 50.4% 43.1% 41.0% 35.0% <0.001
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which implies that it fell more rapidly as the subjects
grew older (−0.059, 95% CI:-0.115, −0.002).
When we calculated the differences at the maximum
and minimum age of the data, we found that the confi-
dence interval for underweight overlapped with the refer-
ence category (22-24.99 kg/m2) at age 25 (0.08, 95% CI:
-0.02, 0.18), but it fell to −.30 (95% CI: −.19, −.41) below
the reference category at age 90 in the fitted model. For
obese subjects, the difference was −0.15 (95% CI: -0.05,
−0.25) below the reference category at age 25 and −0.18
(95% CI: -0.07, −0.29) below at age 90. This implies that
even though a low BMI was slightly beneficial at a young
age, it represented an increasing risk with age, crossing
the reference curve at age 38 and even crossing the obese
trajectory at age 67 in the full fitted model.
BMI and mortality risk
Table 4 shows the mortality rate and hazard ratio for
BMI groups and SRH. The upper normal range (22-
24.99 kg/m2) was our reference category. Subjects with
BMI <18.5 Kg/m2 had twice the mortality rate (0.021) of
the reference category (0.010) and also a higher rate than
that of obese subjects (0.018). Figure 4 (Kaplan-Meier
survival function) displays how the risk of death was
most pronounced for the very thin but also increased
gradually with increasing degrees of overweight. The
Cox proportional hazard model shows that BMI <18.5
Kg/m2 was associated with 69% increased risk of all-
cause death (HR 1.69, 95%CI: 1.38-2.06) and 18.5-22.99
Kg/m2 with a 14% increased risk (1.14, 95% CI: 1.05-
1.25) as compared to the reference category (23-
24.99 kg/m2). The HRs were controlled for age, gender,
comorbidity, mental distress, systolic blood pressure,
cholesterol, physical activity levels and daily smoking.
When entering the updated BMI values measured at
each consecutive wave into the model, we saw that the
hazard ratios increased. This means that weight change
increased the HRs. We built the models hierarchically,
starting with BMI and then adding SRH and the other fac-
tors to the model. Controlled only for age and gender, the
Table 1 Characteristics of all participants for BMI groups for each wave (Continued)
Panel <18.5 18.5-22.99 23-24.99 25-29.99 >30 P-value c
Kg/m2 Kg/m2 Kg/m2 kg/m2 kg/m2
Tromsø 4 59.7% 44.4% 36.4% 31.3% 26.7% <0.001
Tromsø 5 67.5% 41.2% 30.6% 24.7% 18.3% <0.001
Tromsø 6 37.5% 26.3% 22.3% 17.7% 15.9% 0.003
aTromsø 3 and 4 did not include subjects <25 years, Tromsø 5 &6 did not include subjects <30 years
bHII Health impact index which measures comorbidity, MHI Mental health index (Tromsø 4), HSCL Hopkins symptoms checklist (Tromsø 5-6), BPM beats per minute
cComparison of BMI groups were performed utilizing Kruskal-Wallis equality-of-populations rank test for gender, smoking habits and physical activity levels, and
one-way anova for all other variables
Fig. 2 Change in body mass (BMI) for subjects who were underweight at beginning and end of follow-up period with 95% confidence intervals
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hazard ratio for underweight was 2.24 (95% CI: 1.84-2.73).
When controlling for pathology and biometrics, the HR
for the underweight subjects attenuated (HR 1.79, 95% CI:
1.46-2.18). Controlling for SRH alone reduced the HR to
2.05 (95% CI: 1.71-2.46). In the fully fitted model, we find
that even though part of the risk was explained by comor-
bidity and physical condition, the subjects with the lowest
BMI were still associated with a 69% higher mortality risk.
An increasing HR, especially for the very thin, concurs
with SRH being lower than the optimal BMI of 23-
24.99 kg/m2 for the thin as age increases.
We investigated the interactions between gender, co-
morbidity, SRH and BMI, and found that obese men had
a 25% higher risk (1.25, 95% CI: 1.04, 1.50) than obese
women. SRH interacted with observation time, which
implied that the hazard ratio increased with .8% for each
year of observation. This is consistent with the findings
in the latent trajectory model that show that SRH de-
creases with age.
Discussion
This study shows that SRH changed with increasing age,
but age affected the thinnest subjects more than all
others. Underweight was associated with a higher mor-
tality risk, and weight change increased this risk. Several
authors argue that the health consequences of being
underweight might be more severe in terms of prema-
ture mortality and quality of life, compared to being
Table 2 Cross section of Self-reported health for BMI and 10-year age groups for Tromsø 3-6
<18,5 Kg/m2 18,5-22,99 Kg/m2 23-24,99 Kg/m2 25-29,99 Kg/m2 >30 Kg/m2 p-value
Count Mean (SD.) Count Mean (SD.) Count Mean (SD.) Count Mean (SD.) Count Mean (SD.)
Tromsø 3
25-29 88 3.09 (0.64) 1529 3.24 (0.68) 692 3.29 (0.68) 483 3.20 (0.70) 86 3.05 (0.78) 0.008
30-39 138 3.00 (0.74) 31 3.13 (0.70) 1681 3.18 (0.70) 1624 3.06 (0.71) 250 2.80 (0.74) <0.001
40-49 44 2.67 (0.79) 1626 3.00 (0.74) 1338 3.04 (0.73) 1779 2.95 (0.73) 331 2.85 (0.75) <0.001
50-59 27 2.33 (0.87) 741 2.75 (0.81) 777 2.87 (0.79) 1166 2.81 (0.81) 248 2.58 (0.83) <0.001
60-69 2 1.00 79 2.62 (0.82) 100 2.60 (0.81) 174 2.73 (0.77) 30 3.00 (0.65) 0.031
Tromsø 4
25-29 51 2.94 (0.68) 993 3.18 (0.64) 600 3.21 (0.64) 685 3.13 (0.63) 147 2.90 (0.63) <0.001
30-39 70 3.03 (0.59) 2138 3.12 (0.65) 1468 3.10 (0.64) 1784 3.04 (0.61) 396 2.85 (0.66) <0.001
40-49 61 2.67 (0.86) 1853 2.92 (0.66) 1588 2.92 (0.64) 2485 2.89 (0.62) 646 2.70 (0.66) <0.001
50-59 41 2.49 (0.75) 829 2.69 (0.70) 1011 2.78 (0.67) 1914 2.71 (0.65) 610 2.55 (0.66) <0.001
60-69 41 2.17 (0.77) 599 2.50 (0.64) 615 2.52 (0.63) 1364 2.53 (0.63) 469 2.38 (0.62) <0.001
70-79 46 1.96 (0.79) 408 2.40 (0.69) 387 2.45 (0.68) 925 2.42 (0.65) 372 2.28 (0.68) <0.001
> 80 17 2.00 (0.61) 138 2.26 (0.68) 120 2.41 (0.69) 234 2.28 (0.60) 90 2.18 (0.61) 0.034
Tromsø 5
30-39 8 2.75 (0.71) 167 3.14 (0.68) 135 3.13 (0.60) 177 3.05 (0.61) 73 2.99 (0.52) 0.163
40-49 4 2.75 (0.50) 323 3.00 (0.67) 300 3.07 (0.67) 547 2.99 (0.63) 178 2.82 (0.61) 0.002
50-59 7 2.71 (0.76) 156 2.66 (0.69) 197 2.78 (0.65) 481 2.71 (0.62) 237 2.59 (0.62) 0.038
60-69 29 2.34 (0.77) 369 2.64 (0.65) 502 2.71 (0.66) 1234 2.69 (0.63) 549 2.51 (0.59) <0.001
70-79 35 2.21 (0.69) 311 2.46 (0.61) 358 2.59 (0.64) 846 2.54 (0.62) 392 2.40 (0.59) <0.001
> 80 3 1.33 (0.58) 52 2.45 (0.68) 42 2.54 (0.60) 107 2.42 (0.66) 55 2.31 (0.60) 0.024
Tromsø 6
30-39 2 3.00 (0.00) 111 3.04 (0.82) 93 3.04 (0.69) 166 2.96 (0.65) 85 2.71 (0.72) 0.012
40-49 13 3.08 (0.76) 549 3.11 (0.80) 545 3.01 (0.74) 1115 2.94 (0.73) 500 2.66 (0.73) <0.001
50-59 12 2.50 (0.90) 424 2.97 (0.83) 471 2.87 (0.75) 1085 2.79 (0.76) 443 2.58 (0.76) <0.001
60-69 22 2.14 (0.85) 555 2.80 (0.77) 659 2.81 (0.70) 1926 2.70 (0.73) 935 2.49 (0.71) <0.001
70-79 24 2.29 (0.91) 265 2.47 (0.76) 320 2.61 (0.67) 831 2.63 (0.70) 382 2.37 (0.76) <0.001
> 80 7 1.86 (0.69) 92 2.46 (0.72) 87 2.37 (0.72) 232 2.41 (0.74) 109 2.26 (0.71) 0.099
p-value is based on ANOVA. There was a significant effect of BMI for most age groups. Planned contrasts show that overweight and underweight significantly
lowered the SRH, while the differences within the normal range for most groups did not show significant differences
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overweight [8–10, 16–18, 36–38]. Although being thin is
an ideal, and despite the general advice for obese people
to lose weight, our study indicates that being thin could
in itself represent a health risk later in life. Inverse prob-
ability weighting (IPW) showed that loss to follow-up
did not significantly affect this result, which supports
the causal claim that being thin drives the later decline.
It is interesting that normalizing the weight resulted in
fewer comorbid conditions and lower mortality rates,
and yet, lower SRH. SRH is strongly associated with bio-
logical factors, however, it is also known to be sensitive
to factors such as coping skills, as well as mental dis-
tress, and social context [39]. One plausible explanation
could be that general health advice is focused on losing
weight, while normalizing the weight for underweight
persons will imply gaining weight. This study cannot
Table 3 Results from the complete case (CC) and inverse probability weighted (IPW) models with estimates for the association of
subject-specific factors on Self-Reported Health trajectories
CC IPW
Coef. 95% CI. Coef. 95% CI.
Body mass index
< 18.5 Kg/m2 0.238 −0.040 0.515 0.222 −0.091 0.536
18.5-22.99 Kg/m2 0.101 0.020 0.182 0.091 0.007 0.175
22-24.99 kg/m2 0.000 Reference 0.000 Reference
25-29.99 kg/m2 −0.042 −0.118 0.035 −0.033 −0.112 0.045
> 30 kg/m2 −0.173 −0.283 −0.063 −0.137 −0.252 −0.021
BMI*age
< 18.5 Kg/m2 −0.063 −0.112 −0.013 −0.058 −0.113 −0.002
18.5-22.99 Kg/m2 −0.015 −0.031 0.000 −0.014 −0.029 0.002
22-24.99 kg/m2 0.000 Reference 0.000 Reference
25-29.99 kg/m2 −0.001 −0.015 0.013 −0.003 −0.017 0.011
> 30 kg/m2 0.002 −0.017 0.022 −0.004 −0.024 0.016
age (pr 10 years) 0.951 0.137 1.766 0.933 0.055 1.810
age2 −0.333 −0.572 −0.095 −0.341 −0.597 −0.085
age3 0.043 0.013 0.073 0.045 0.013 0.077
age4 −0.002 −0.003 −0.001 −0.002 −0.004 −0.001
Observation time (year) −0.005 −0.006 −0.003 −0.004 −0.006 −0.003
Gender −0.018 −0.034 −0.002 −0.010 −0.026 0.007
Specific medical conditions −0.071 −0.075 −0.067 −0.063 −0.068 −0.059
Mental distress (standardized) −0.222 −0.230 −0.215 −0.210 −0.218 −0.201
Resting heart rate (Standardized) −0.040 −0.047 −0.032 −0.040 −0.049 −0.032
Systelic blood pressure (pr 10 mmHg) 0.003 −0.001 0.007 0.000 0.000 0.000
Total cholesterol 0.000 0.000 0.001 0.001 −0.005 0.008
Physical activity (4 levels)
Inactive 0.000 Reference 0.000 Reference
Light 0.102 0.085 0.119 0.091 0.073 0.108
Moderate 0.177 0.159 0.196 0.158 0.139 0.178
Intensive 0.212 0.187 0.237 0.192 0.165 0.218
Daily smoking (yes/no) −0.092 −0.108 −0.076 −0.085 −0.102 −0.068
Constant 2.321 1.307 3.335 2.376 1.281 3.471
Random part
Variance (constant) 0.111 0.105 0.117 0.165 0.158 0.171
Variance (Residual) 0.235 0.229 0.241 0.185 0.180 0.190
Complete case model (CC): Mixed-effects ML regression model, Wald chi2(23) =9184.16, Log likelihood = −25,102.758, P < 0.0001
Inverse probability weighted model (IPW): Mixed-effects ML regression model with inverse probability weighting for differential attrition, Wald chi2(23) =7683.26,
Log likelihood = −29,943.958, P < 0.0001
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answer questions regarding health beliefs, but this could
be addressed using qualitative methods.
Previous studies have shown that persons with BMI of
<18.5 kg/m2 and ≥30 kg/m2 report impaired quality of
life and SRH [40, 41]. Our study shows that this depends
on age. Having a BMI above 30 kg/m2 was never benefi-
cial for SRH as compared to the normal BMI range,
while those with BMI below 18.5 kg/m2 started out with
more beneficial levels but had a far more negative SRH
trajectory as age increased. For underweight subjects, we
see a positive gap in SRH scores compared to the other
categories, but they fell more rapidly with age.
Consequently, a low BMI was slightly beneficial at a
young age, but it represented an increasingly negative
factor with age, passing below the reference category at
age 38 and even below the trajectory of obese subjects at
age 67 in the fully fitted model.
Previous studies have shown that subjects who re-
ported being obese in young adulthood only or in both
young and middle adulthood experienced mortality rates
that were 40%–90% higher than those subjects who were
non-obese at either time [42]. Our study showed a simi-
lar association, but even higher rates for those who were
very thin, with a 69% higher all-cause death risk (1.69,
Fig. 3 Self-reported health trajectories according to weight groups and age
Table 4 Mortality rates and hazard ratio for all-cause mortality between categories of body mass index in the Tromsø study 1986-
2008 until end of follow up on December 31, 2015
Person Time (Years) Died Mortality rate Hazard ratio a 95% CI
Body mass index
< 18.5 Kg/m2 5121 109 0.021 1.69 (1.38- 2.06)
18.5-22.99 Kg/m2 129,676 1122 0.009 1.14 (1.05- 1.25)
23-24.99 kg/m2 (ref) 107,253 1026 0.010 1.00 Reference
25-29.99 kg/m2 169,612 2160 0.013 0.97 (0.90- 1.05)
> 30 kg/m2 46,709 855 0.018 1.12 (1.02- 1.23)
Self-Reported Health
Poor 10,762 416 0.039 2.54 (1.88- 3.45)
Not so good 117,369 2581 0.022 1.94 (1.55- 2.43)
Good 259,293 2045 0.008 1.30 (1.10- 1.54)
Very good (ref) 70,947 230 0.003 1.00 Reference
Time varying covariates
Self-Reported Health 0.004 (1.00- 1.02)
aHazard ratios (HR) are based on Cox proportional hazard and includes both SRH and BMI controlled for age, gender, comorbidity, mental health symptoms,
systolic blood pressure, cholesterol, physical activity levels and daily smoking. For HRs shown in Table 4, is SRH time-varying but BMI time-invariant
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95% CI: 1.38-2.06) as compared to only 12% for obese
subjects (1.12, 95% CI: 1.02-1.23). The estimate is based
on the baseline BMI at study entry. It indicates that
starting as thin represented a mortality risk even though
the body weight may change later in life, and although
reaching a normal weight was beneficial for them.
The most underweight subjects were females among
the youngest (<30 years) and oldest (>70 years) subjects.
This is consistent with the difference we found between
the group that started out as underweight and those
who ended up as underweight. A Swedish study
concluded that persons aged 75-90 who were overweight
had a lower mortality risk than old persons with a BMI
below 25 [43]. This is consistent with our findings for
persons aged >67. Our study further shows that under-
weight in young age also represented a risk, even though
underweight in younger adults is more likely to be
associated with other medical issues (e.g. % fat mass),
while in older adults underweight BMI could be an indi-
cator of sarcopenia [44], malnutrition or other clinical
conditions [6, 12].
Our models examined how body mass affected two
different aspects of health. Mortality concerns survival,
while SRH reflects the quality of survival. Being under-
weight affected both mortality and SRH negatively, while
gaining weight had a negative association with all-cause
mortality but might be beneficial for SRH. Weight loss is
known to have a potential negative effect on health [13,
16–19, 21, 22]. Hence, it is reasonable to ask if the find-
ings of our study are more a question of becoming,
rather than being, underweight. The negative trajectory
is explained as a combination of within-subject effects
(i.e. becoming underweight) and between-subject effects
(i.e. being underweight). It implies that changing BMI
category (i.e. adding weight for those who were under-
weight) can affect SRH. However, when examining the ef-
fect of weight change in individual subjects, we find that
weight gain was associated with lower SRH levels, even
for those with a very low body mass. Although we would
advise overweight persons to lose weight towards the nor-
mal range, gaining weight as general advice for under-
weight persons does not necessarily lead to better SRH.
Mortality was not affected by weight change in the
same manner. The baseline BMI predicted a 69% in-
creased risk, and when we modeled weight change by
updating BMI values, we found that the risk increased to
79%, while for those in the lower normal range, the risk
increased from 14% to 19%. This is consistent with a
previous study of the Tromsø study cohort that showed
that weight loss and gain were associated with increased
all-cause mortality for men and in the subgroup of
women who reported no weight-loss attempts [20].
Our study suggests that there is a healthy and an un-
healthy underweight group, and that thinness due to
waste is a risk. It seems plausible to distinguish between
those who were initially underweight and those who be-
came underweight (e.g. due to malnutrition). There are
studies of nutrition and BMI status among older persons
[6], but there are no studies that identify subgroups at
risk among younger subjects. Our models control for
known physical diseases, but not for eating disorders.
Further studies should try to identify subgroups at par-
ticular risk among underweight persons. Health-related
behavior explained 17% of the variance in our data,
while gender and age (21%), comorbidity (23%) and
mental distress (28%) are therefore important factors for
Fig. 4 Kaplan-Meier survival function according to body mass index from 1994 to 2015
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an understanding of the decline. Our study suggests fol-
lowing up particularly gender differences, smoking sta-
tus, the effect of weight change and development of
comorbid diseases later in life.
We find more persons who exercise among the under-
weight subjects. This is consistent with being thin as part
of a healthy life, but at the same time we find more per-
sons who lead active lives and more non-smokers among
the obese than we find from <25 kg/m2. It is timely to ask
whether this might be an indication that health informa-
tion is primarily targeting overweight subjects.
Limitations
The Tromsø study was designed to represent a general
population. Our latent trajectory model utilized 48.3% of
TS 3, 45.3% of TS 4, 84.5% of TS 5 and 74.9% of TS 6.
We used inverse probability weighting (IPW) to examine
how the missing data affected the main finding of this
study. IPW lowered the estimate for thin subjects and
raised it for overweight subjects. The interaction with
age attenuated, but the overall effect of age increased.
The difference was that the underweight trajectory was
equal in the CC and IPW models at age 25 (3.03) but
ended 0.06 (3.5%) lower at age 90 in the weighted model.
We see that loss to follow-up had a greater effect on the
overweight (4.7%) and obesity groups (5.4%). The in-
creased decline in the IPW model is consistent with the
assumption that subjects well enough to participate sev-
eral times are slightly healthier, but even so, loss to
follow-up did not affect our overall results. Table 3
shows that confidence intervals (CIs) widened in the
weighted model, but not substantially. No variable that
was non-significant has become significant, or vice versa
(except for gender and blood pressure that had CIs very
close to zero). The findings thus remained basically
unchanged by IPW, although there is an indication that
the effect of ageing may be stronger in the general popu-
lation than suggested by the CC analysis for under- and
overweight subjects.
The survival analysis utilized the entire TS4 panel. Be-
ing able to use updated values reduces the bias in spite
of missing data in the updated measurements. 51.3% of
the participants attended only in TS4, 17.6% participated
in all panels, while 31.1% reappeared in either TS5 or
TS6. Using multiple imputation showed that missing
data did not affect the estimates at the decimal level
shown. We therefore conclude that the selection bias is
within reasonable limits for both models.
It is of interest that the prevalence of underweight
declined, but Tromsø 5-6 did not include participants
<35 years and TS3 did not include participants >70 years,
where we found most of the underweight subjects. No
conclusions can therefore be drawn on the prevalence of
underweight from this study. The small sample size of
underweight individuals makes it difficult to fully analyze
the causal claim of interest, but we can conclude that
there are associations between underweight, self-
reported health trajectories and mortality rates and that
this relationship varies with age.
Although measured on an ordinal scale, the underlying
phenomenon of SRH is continuous, and the scales repre-
sent similar logical increments. Furthermore, the distri-
bution of SRH, apart from being staggered, resembled
the shape of a normal distribution. Hence, an OLS
regression model could be used for the analysis of inde-
pendent associations in the multivariable model [45].
Conclusion
BMI affected SRH and all-cause mortality independently
from comorbidity, mental health, other biological risk
factors or health-related behaviors. Being underweight
was associated with excess mortality as compared to all
other weight categories, and age affected the thinnest
subjects more than all others. Weight increase was
beneficial for mortality but not for SRH among the
underweight. The rapid decline of SRH with increasing
age suggests that particular attention should be paid to
underweight subjects after 38 years of age.
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